Dr. Eric S. Guglielmo, MD

Dr. Guglielmo practices at Florida Retina Specialists, P.A. in Merritt Island, Florida.

Dr. Guglielmo's NPI, 1093866840, was assigned on January 16, 2007. Dr. Guglielmo graduated from UNR Med in 2005. Dr. Guglielmo holds Florida license ME166547.

Dr. Guglielmo's primary practice is Florida Retina Specialists, P.A., at 280 Sykes Creek N Pkwy, Merritt Island, FL 32953 in Brevard County. The practice phone is (321) 735-8800.

Dr. Guglielmo's primary practice is Florida Retina Specialists, P.A. in Merritt Island, Florida. Dr. Guglielmo is also affiliated with Cape Canaveral Hospital. Dmand AI also links Dr. Guglielmo to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Guglielmo practices, 2 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Guglielmo's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Guglielmo is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Guglielmo's licenses on file in 4 states: Florida, Washington, West Virginia and Oklahoma.

CMS data shows 1,334 Medicare services from Dr. Guglielmo across 10 procedure codes in 2024, for 274 Medicare patients. Medicare paid $148,364 for them. Every service was in an office.

CMS counts 274 Medicare patients who saw Dr. Guglielmo in 2024. The largest group is 65 to 74, with 131 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Guglielmo's median patient age at 74, with 51% women.

In 2024, Dr. Guglielmo wrote 87 Medicare Part D claims for 38 patients. 57% of them were for generic drugs. CMS names the drug for 45 of them, across 2 drugs with 11 or more claims each, at $1,242 in total drug cost. In 2021, CMS named 180 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Guglielmo for performance year 2024, reported as part of a group. Dr. Guglielmo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 30 general payments to Dr. Guglielmo from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $510.

Dmand AI lists 1 award for Dr. Guglielmo, most recently CMS Stage 1 EHR in 2013.

Dr. Guglielmo graduated from UNR Med in 2005.

Dr. Guglielmo is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.